These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7561223)

  • 1. Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration.
    Mignault GG; Latreille J; Viguié F; Richer P; Lemire F; Harsanyi Z; Stewart JH
    J Pain Symptom Manage; 1995 Aug; 10(6):416-22. PubMed ID: 7561223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
    Gourlay GK; Cherry DA; Onley MM; Tordoff SG; Conn DA; Hood GM; Plummer JL
    Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.
    Cundiff D; McCarthy K; Savarese JJ; Kaiko R; Thomas G; Grandy R; Goldenheim P
    Cancer; 1989 Jun; 63(11 Suppl):2355-9. PubMed ID: 2720581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
    Thirlwell MP; Sloan PA; Maroun JA; Boos GJ; Besner JG; Stewart JH; Mount BM
    Cancer; 1989 Jun; 63(11 Suppl):2275-83. PubMed ID: 2720576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.
    Goughnour BR; Arkinstall WW; Stewart JH
    Cancer; 1989 Jun; 63(11 Suppl):2294-7. PubMed ID: 2720578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW; Goughnour BR; White JA; Stewart JH
    CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
    Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
    J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.
    Broomhead A; Kerr R; Tester W; O'Meara P; Maccarrone C; Bowles R; Hodsman P
    J Pain Symptom Manage; 1997 Aug; 14(2):63-73. PubMed ID: 9262035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain.
    Hays H; Hagen N; Thirlwell M; Dhaliwal H; Babul N; Harsanyi Z; Darke AC
    Cancer; 1994 Sep; 74(6):1808-16. PubMed ID: 7521784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.
    Hagen NA; Thirlwell M; Eisenhoffer J; Quigley P; Harsanyi Z; Darke A
    J Pain Symptom Manage; 2005 Jan; 29(1):80-90. PubMed ID: 15652441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation.
    Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
    J Clin Oncol; 1995 Jun; 13(6):1520-7. PubMed ID: 7751901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer pain. A randomized controlled trial.
    Bruera E; Belzile M; Neumann CM; Ford I; Harsanyi Z; Darke A
    Support Care Cancer; 1999 Jul; 7(4):280-3. PubMed ID: 10423055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a controlled-release oral morphine for cancer pain management.
    Kim BS; Chung HC
    Postgrad Med J; 1991; 67 Suppl 2():S82-6. PubMed ID: 1758823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain.
    Rodríguez M; Barutell C; Rull M; Gálvez R; Pallarés J; Vidal F; Aliaga L; Moreno J; Puerta J; Ortiz P
    Eur J Cancer; 1994; 30A(5):584-7. PubMed ID: 8080670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain.
    Chary S; Goughnour BR; Moulin DE; Thorpe WR; Harsanyi Z; Darke AC
    J Pain Symptom Manage; 1994 Aug; 9(6):363-71. PubMed ID: 7963789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic efficacy and safety of two oral controlled-release morphine preparations in orthopedic postoperative pain.
    Cooper SA; Fitzmartin R; Slywka J; Buckley BJ; Kaiko R; Goldenheim PD; Mooar P; Witte JF; Hersh EV
    Adv Ther; 1994; 11(5):213-27. PubMed ID: 10150266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients.
    Portenoy RK; Maldonado M; Fitzmartin R; Kaiko RF; Kanner R
    Cancer; 1989 Jun; 63(11 Suppl):2284-8. PubMed ID: 2720577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer pain management with a controlled-release oral morphine preparation.
    Lapin J; Houde RW; Kaiko RF; Coyle N; Rogers A; Foley KM
    J Pain Symptom Manage; 1989 Sep; 4(3):146-51. PubMed ID: 2778362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.